Brachytherapy
Volume 5, Issue 4 , Pages 235-238 , October 2006

Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields

Received 30 December 2005 ,Revised 21 August 2006 ,Accepted 21 August 2006.

References 

  1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  2. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet. 2000;355:1757–1770
  3. Taghian A, Assaad S, Niermierko A, et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. Int J Radiat Oncol Biol Phys. 2005;62:386–391
  4. Choi YW, Munden RF, Erasmus JJ, et al. Effects of radiation therapy on the lung: Radiologic appearances and differential diagnosis. Radiographics. 2004;24:985–997discussion 998
  5. Delouche G, Bachelot F, Premont M, et al. Conservation treatment of early breast cancer: Long term results and complications. Int J Radiat Oncol Biol Phys. 1987;13:29–34
  6. Vallis KA, Pintilie M, Chong N, et al. Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer. J Clin Oncol. 2002;20:1036–1042
  7. Nag S, Gupta N. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys. 2000;46:507–513
  8. Abratt RP, Morgan GW, Silvestri G, et al. Pulmonary complications of radiation therapy. Clin Chest Med. 2004;25:167–177
  9. Hurkmans CW, Borger JH, Bos LJ, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol. 2000;55:145–151
  10. Hurkmans CW, Cho BC, Damen E, et al. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol. 2002;62:163–171
  11. Cazzaniga LF, Bossi A, Cosentino D, et al. Radiological findings when very small lung volumes are irradiated in breast and chest wall treatment. Radiat Oncol Investig. 1998;6:58–62
  12. Graham MV, Purdy JA, Emami B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323–329
  13. Marks LB, Yu X, Zhou S, et al. The impact of irradiated left ventricular volume on the incidence of radiation-induced cardiac perfusion changes. Int J Radiat Oncol Biol Phys. 2003;57:S129
  14. Theuws JC, Kwa SL, Wagenaar AC, et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 1998;49:233–243
  15. Theuws JC, Kwa SL, Wagenaar AC, et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma and breast cancer. Radiother Oncol. 1998;48:33–43
  16. Gopal R, Starkschall G, Tucker SL, et al. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2003;56:114–120
  17. Gopal R, Tucker SL, Komaki R, et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys. 2003;56:106–113
  18. Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. Med Phys. 1995;22:209–234
  19. Dawson B, Trapp RG. Basic & clinical biostatistics. New York: Appleton & Lange; 2001;p. 114–115

PII: S1538-4721(06)00240-6

doi: 10.1016/j.brachy.2006.08.001

Brachytherapy
Volume 5, Issue 4 , Pages 235-238 , October 2006

Article Tools

* Image Usage & Resolution